Alphabet Inc.

Institutional investor · Portfolio as of Q1 2023

Top Holdings49 positions

Checking export access…
Activity:
PATH

UiPath, Inc.

14.1M$247M13.7%$67.93-74.15%
8 qtrssince 2021-Q2
Unchanged
0
PRME

Prime Medicine, Inc.

13.3M$163.4M9.1%$18.58-33.80%
2 qtrssince 2022-Q4
Unchanged
0
CRWD

CrowdStrike Holdings, Inc.

1.2M$159.7M8.9%$30.04+14.22%
2 qtrssince 2022-Q4
Increased
93
OSCR

Oscar Health, Inc.

24M$157.2M8.7%$26.88-75.67%
9 qtrssince 2021-Q1
Unchanged
0
VERV
VERVDelisted

VERVE THERAPEUTICS INC

10.5M$152.1M8.4%——
8 qtrssince 2021-Q2
Unchanged
0
DXCM

DexCom, Inc.

1.3M$145.2M8.1%$77.24+50.41%
15 qtrssince 2019-Q3
Unchanged
0
PL

Planet Labs PBC

31.9M$125.5M7.0%$6.15-36.10%
6 qtrssince 2021-Q4
Unchanged
0
EQRX
EQRXDelisted

EQRX Inc

47.7M$92.5M5.1%——
6 qtrssince 2021-Q4
Unchanged
0
SNOW

Snowflake Inc.

535,604$82.6M4.6%$229.13-32.66%
5 qtrssince 2022-Q1
Unchanged
0
DUOL

Duolingo, Inc.

523,824$74.7M4.1%$109.82+30.16%
7 qtrssince 2021-Q3
Decreased
0
GTLB

GitLab Inc.

1.9M$66.3M3.7%$44.12-22.28%
4 qtrssince 2022-Q2
Increased
76
FRSH

Freshworks Inc.

4M$62M3.4%$26.26-41.51%
6 qtrssince 2021-Q4
Unchanged
0
HOOD

Robinhood Markets, Inc.

4.9M$47.9M2.7%$42.08-76.92%
7 qtrssince 2021-Q3
Unchanged
0
LYFT

Lyft, Inc.

3.7M$34.3M1.9%$40.84-77.30%
15 qtrssince 2019-Q3
Decreased
0
RLAY

Relay Therapeutics, Inc.

1.6M$25.8M1.4%$41.71-60.51%
11 qtrssince 2020-Q3
Unchanged
0
DM
DMDelisted

Desktop Metal Inc

11M$25.4M1.4%——
10 qtrssince 2020-Q4
Unchanged
0
BHIL
BHILDelisted

Benson Hill Inc

15.4M$17.7M1.0%——
7 qtrssince 2021-Q3
Unchanged
0
ME
MEDelisted

23ANDME HOLDING CO

6.7M$15.4M0.9%——
6 qtrssince 2021-Q4
Unchanged
0
LYEL

Lyell Immunopharma, Inc.

5.9M$13.8M0.8%$324.80-85.47%
8 qtrssince 2021-Q2
Unchanged
0
ILMN

Illumina, Inc.

53,470$12.4M0.7%$394.56-42.67%
7 qtrssince 2021-Q3
Unchanged
0
$1.8B
AUM
49
Positions
Q1 2023
Filing
HI rating · 2.5/5
Quarterly 13F Value Change
Reported 13F value ($B)
Reported 13F values and quarter-over-quarter reported value changes; not investment returns.
QuarterReported value in US dollarsReported value change
2021-Q4$4,141,375,000-1.74902220541%
2022-Q1$3,082,033,000-25.5794754158%
2022-Q2$1,842,489,000-40.2183883171%
2022-Q3$1,958,351,0006.28834147721%
2022-Q4$1,721,793,620-12.0794168155%
2023-Q1$1,803,455,9954.74286662765%
Activity profile
$ moved · Q1'23
New0%Increased63%Decreased31%Exited5%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg <1 quarter
<1Q2%1-4Q98%1-2Y0%2Y+0%

Alphabet Inc. manages $1.8B across 49 positions as of Q1 2023. Top holdings: PATH (13.7%), PRME (9.1%), CRWD (8.9%). Fund DNA: Concentrated Value. HoldingsIntel Score: 2.5/5.0.

Q1 2023 Summary

Added MONDQ; exited NEWR, AMPL and VLD; increased 3, led by GTLB (+639,207 shares); trimmed 4, led by DUOL (−180,620 shares). Top move: CRWD (INCREASED, conviction 93). Portfolio: $1.8B across 49 positions.

Top holdings by portfolio weight

Total AUM$2B
PATH13.70%
PRME9.06%
CRWD8.86%
OSCR8.72%
VERV8.43%
DXCM8.05%
PL6.96%
EQRX5.13%
SNOW4.58%
DUOL4.14%
Other3.68%

Portfolio allocation by GICS sector

Sectors5
Technology40.35%
Healthcare32.70%
Unknown17.30%
Industrials6.97%
Financial Services2.68%

Behavioral investing profile

Checking access…
Concentrated Value- primarily Technology, Healthcare, Unknown
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Solid(2.5 / 5.0)
Holdings P&L42
Conviction73
Concentration100
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

No active accumulation streaks detected for this filer.

Streaks require 2+ consecutive quarters of increased positions in the most recent period.

Famous Investors' Portfolios

What the most-followed managers hold, and what they bought and sold each quarter.

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used